Empagliflozin treatment effects across categories of baseline <scp>HbA1c</scp> , body weight and blood pressure as an add‐on to metformin in patients with type 2 diabetes

Empagliflozin, as add-on to metformin, decreases HbA1c and BW, particularly in patients with higher HbA1c and BW baseline values, and effectively lowers SBP.